ClinicalTrials.gg
Drug

Asparaginase erwinia chrysanthemi clinical trials

Also written Erwinase, Crisantaspase and Rylaze™.

studies test it
21
open now
3
in phase 3
6
first study started
1997

How each study uses asparaginase erwinia chrysanthemi is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the asparaginase erwinia chrysanthemi studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Nov 2011 · Erwinaze · BLA 125359 (FDA, Purple Book)
European Union
15 Sept 2023 · Enrylaze · EMEA/H/C/005917 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Asparaginase Erwinia chrysanthemi
8
Erwinia chrysanthemi
2
Recombinant Erwinia
2
Asparaginase
2
L-Asparaginase
2

Brand

Erwinase
8
Rylaze™
2
Erwinaze®
1

Other names

Crisantaspase
4
Erwinia asparaginase
3
Erwinia L-Asparaginase
3

Studies by the year they started

21 studies that test it; most in 2007 (2)

Studies that test asparaginase erwinia chrysanthemi, by start year
YearStudies
19971
20001
20031
20061
20072
20091
20122
20142
20151
20161
20172
20181
20191
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
11
Phase 3
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 18

St. Jude Children's Research Hospital (9) · Jazz Pharmaceuticals (3) · M.D. Anderson Cancer Center (2) · City of Hope Medical Center (2) · Children's Oncology Group (1) · Ashkan Emadi (1) · Baylor College of Medicine (1) · University of Washington (1)

Often tested with

Tested in the same studies.

Etoposide (9) · Cytarabine (8) · Methotrexate (7) · Dexamethasone (7) · Pegaspargase (7) · Cyclophosphamide (7) · Mercaptopurine (7) · Vincristine (7)

Studies

Open first, then newest update. How each study uses asparaginase erwinia chrysanthemi is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test asparaginase erwinia chrysanthemi →

Given beside what is tested · 14 — asparaginase erwinia chrysanthemi is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with asparaginase erwinia chrysanthemi

Codes

What other systems call asparaginase erwinia chrysanthemi · ClinicalTrials.gg INT001667

  • MeSH (NLM) C000718243asparaginase erwinia chrysanthemiConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) D733ET3F9OASPARAGINASE ERWINIA CHRYSANTHEMIConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C64260Asparaginase Erwinia chrysanthemiOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.